119149 Sigma-AldrichAdenosine A2A Receptor Antagonist I, ZM 241385 - CAS 139180-30-6 - Calbiochem
A highly potent, selective, non-xanthine adenosine A2A receptor antagonist (Ki = 800 pM for human adenosine A2AR stably expressed in HEK-293 cells).
More>> A highly potent, selective, non-xanthine adenosine A2A receptor antagonist (Ki = 800 pM for human adenosine A2AR stably expressed in HEK-293 cells). Less<<Synonyms: 4-(2-((7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino)ethyl)phenol, ZM-241385, ZM241385
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
139180-30-6 | C₁₆H₁₅N₇O₂ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
119149-5MG |
|
Glass bottle | 5 mg |
|
— |
References | |
---|---|
References | Poucher, S. M., et al. 1995. Brit. J. Pharmacol. 115, 1096. Ongini, E. et al. 1999. Naunyn Schmiedebergs Arch Pharmacol. 359, 7. Keddie, J. et al. 1996, Eur Journ Pharm. 301, 107. |
Product Information | |
---|---|
CAS number | 139180-30-6 |
Form | White to beige powder |
Hill Formula | C₁₆H₁₅N₇O₂ |
Chemical formula | C₁₆H₁₅N₇O₂ |
Reversible | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | A2A |
Primary Target K<sub>i</sub> | 800 pM |
Purity | ≥97.5% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
119149-5MG | 04055977223385 |
Documentation
Adenosine A2A Receptor Antagonist I, ZM 241385 - CAS 139180-30-6 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
119149 |
References
Reference overview |
---|
Poucher, S. M., et al. 1995. Brit. J. Pharmacol. 115, 1096. Ongini, E. et al. 1999. Naunyn Schmiedebergs Arch Pharmacol. 359, 7. Keddie, J. et al. 1996, Eur Journ Pharm. 301, 107. |